2 Biotech Stocks to Buy Hand Over Fist in April [Yahoo! Finance]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Yahoo! Finance
only be phased out once we find an all-purpose cure for all illnesses. Further, biotechs often deliver better-than-average financial results during economic downturns because the products they sell are considered necessary goods. Of course, not every biotech company is worth investing in. Let's consider two that are a buy this month, or in most months, for that matter: Amgen (NASDAQ: AMGN) and Sarepta Therapeutics (NASDAQ: SRPT) 1. Amgen Amgen hasn't been at its best over the past couple of years. Revenue growth has been slow, at best, regulatory progress hasn't been as groundbreaking as it would have liked, and the new medicines tasked to replace older ones haven't lived up to expectations, at least not yet. That includes Amjevita, the first biosimilar for Humira to be launched in the U.S. Though AbbVie's Humira hit peak annual sales of $21.2 billion, the fierce competition following its loss of patent exclusivity meant Amgen's product was unable to generate enough sales to m
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]Yahoo! Finance
- Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics to Announce First Quarter 2024 Financial ResultsBusiness Wire
- GSK Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus [Yahoo! Finance]Yahoo! Finance
SRPT
Earnings
- 2/28/24 - Beat
SRPT
Sec Filings
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- SRPT's page on the SEC website